key: cord-0922209-ypv71qg2
authors: Liu, Kefang; Pan, Xiaoqian; Li, Linjie; Yu, Feng; Zheng, Anqi; Du, Pei; Han, Pengcheng; Meng, Yumin; Zhang, Yanfang; Wu, Lili; Chen, Qian; Song, Chunli; Jia, Yunfei; Niu, Sheng; Lu, Dan; Qiao, Chengpeng; Chen, Zhihai; Ma, Dongli; Ma, Xiaopeng; Tan, Shuguang; Zhao, Xin; Qi, Jianxun; Gao, George F.; Wang, Qihui
title: Binding and molecular basis of the bat coronavirus RaTG13 virus to ACE-2 in humans and other species
date: 2021-05-24
journal: Cell
DOI: 10.1016/j.cell.2021.05.031
sha: 2a59978a9ba28add96ee1f99dec9627bff737cf6
doc_id: 922209
cord_uid: ypv71qg2

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been spreading worldwide and causing a global pandemic. Bat-origin RaTG13 is currently the most phylogenetically related virus. Here, we obtained the complex structure of RaTG13 receptor binding domain (RBD) with human ACE2 (hACE2), and further evaluated the binding of RaTG13 RBD to 24 additional ACE2 orthologs. By substituting residues in RaTG13 RBD with their counterparts in SARS-CoV-2 RBD, we found that residue 501, the major position found in VOCs 501Y.V1/V2/V3, plays a key role in determining the potential host range of RaTG13. We also found that SARS-CoV-2 could induce strong cross-reactive antibodies to RaTG13 and identified a SARS-CoV-2 MAb, CB6, that could cross-neutralize RaTG13 pseudovirus. These results elucidate the receptor binding and host-adaption mechanisms of RaTG13 and emphasize the importance of continuous surveillance of coronaviruses (CoVs) carried by animal reservoirs to prevent another spill-over of CoVs.

pandemic. For example, RmYN02, another bCoV detected in Rhinolophus malayanus, 81 shares 93.3% nucleotide identity with the SARS-CoV-2 genome, and contains three 82 amino acid residue (PAA) insertions at the S1/S2 cleavage site of its S protein, which 83 is similar to that in SARS-CoV-2 (Zhou et al., 2020a) . Considering the similarity 84 between RaTG13 and SARS-CoV-2 and the devastation caused by SARS-CoV-2, 85 RaTG13 may pose a significant threat to humans and other animals. To access this 86 risk, the host range of RaTG13 needs to be investigated. 87 the underlying mechanism for the lower binding affinity of RaTG13 RBD compared 114 to that of SARS-CoV-2 RBD to hACE2 was resolved. Moreover, the binding ability 115 of 24 ACE2 orthologs, together with hACE2, to RaTG13 RBD was quantified. We 116 also evaluated the effects of six substitutions between RaTG13 RBD and 117 SARS-CoV-2 RBD on the interaction with hACE2 and orthologs. Specifically, 501 is 118 most likely the key residue that determines the potential host range of RaTG13. 119 Coincidentally, residue 501 is also the key mutation of the SARS-CoV-2 strains that 120 have been rapidly spreading in many countries, including variant of concern (VOC) densities of residues S19 to A614 of hACE2 and residues T333 to P527 of RaTG13 157 RBD are clearly observed. Five N-glycans linked to N53, N90, N103, N322 and N546 158 on hACE2 and one N-glycan linked to N343 of RaTG13 RBD were identified 159 ( Figure 1D ). 160 Overall, the complex structure of RaTG13 RBD with hACE2 is extremely similar Similar to other beta CoV RBDs, RaTG13 RBD consists of a core subdomain and an 164 external subdomain (Han et al., 2017) . The external subdomain is dominated by a 165 disulfide bond-stabilized flexible loop that connects two small β strands ( Figure 1D ). 166 The binding interface of hACE2 with RaTG13 RBD is distributed into two patches.

Patch 1 is located on the N-terminal α1 and α2 helixes, and Patch 2 is on the 168 conformational surface consisting of the residues from α1, together with a β-hairpin 169 constituted by β3 and β4. In Patch 1, residues S19, K31 from α1 and Y83 from α2 170 form a hydrogen bond network with residues S477, Y493, N487 and Y489 of 171 RaTG13 RBD ( Figure 1E and G, Table 2 ). In Patch 2, residues D38, Q42 and Y41 172 from α2 and K353 from the loop linking β3 and β4 form a hydrogen bond network 173 with residues Y498, T500 and G502 ( Figure 1F and H, Table 2 ). The total contact number of RaTG13 RBD with hACE2 (113 contacts) are 178 significantly less than that of SARS-CoV-2 with the same receptor (141 contacts).

Specifically, there are 48 contacts between RaTG13 RBD and hACE2 in Patch 1, 180 which is fewer than that in the SARS-CoV-2 RBD with hACE2 complex (60 contacts) 181 ( Figure 1G) . Similarly, in Patch 2, fewer contacts are formed between RaTG13 RBD 182 and hACE2 than those between SARS-CoV-2 RBD and hACE2 (65 vs. 81) ( Figure   183 1H). Moreover, there are substantially fewer hydrogen bonds in Patch 2 of RaTG13 184 RBD with hACE2 than those of the SARS-CoV-2 RBD with hACE2 complex (4 vs. 9) 185 ( Figure 1H ). 186 The buried surface area of RaTG13 RBD to hACE2 is 1604 Å 2 , which is smaller 187 than that of the SARS-CoV-2 RBD with hACE2 complex (1773 Å 2 ). Specifically, 188 residues G446 and F490 of SARS-CoV-2 RBD contributed to contact with hACE2, 189 whereas the corresponding residues of RaTG13 RBD (G446 and Y490) did not 190 ( Figure 1I ). On the binding surface with hACE2, RaTG13 RBD displays six 191 differences compared to SARS-CoV-2 RBD, namely Y449F, F486L, Q493Y, Q498Y, 192 N501D and Y505H ( Figure 1J ). Afrotheria (lesser hedgehog tenrec) ( Figure S1C ). The 16 key residues in hACE2 204 responsible for the interaction with RaTG13 RBD were highlighted and compared 205 with the 24 ACE2 orthologs. Sequence alignment showed a range of 0 to 9 residue 206 substitutions in the ACE2 orthologs. Overall, residues distributed in Patch 1 are more 207 diverse than residues in Patch 2 ( Figure S1C ). Specifically, residues F28 and D355 208 are fully conserved among all the ACE2 orthologs compared in this study. Residues 209 S19, Y41, Q42, L45, G354 of hACE2 were substituted in no more than three ACE2 210 orthologs among the 24 species ( Figure S1C ). 211 We subsequently tested the binding of ACE2 orthologs with RaTG13 RBD or with 212 SARS-CoV-2 RBD using eGFP-fused ACE2 orthologs expressed on the cell surface in-depth analysis. Horse ACE2 was chosen because it binds to RaTG13 RBD with a 294 higher affinity than that of hACE2, whereas mouse ACE2 was chosen for its distinct 295 binding feature to RaTG13 RBD and SARS-CoV-2 RBD. As the origin of RaTG13, 296 the intermediate horseshoe bat ACE2 was also included in this analysis.

Our results showed a broad spectrum of binding ability to these ACE2 orthologs (Table S3) . 301 The D501N mutant displayed increased binding affinities to the ACE2s of human and 302 intermediate horseshoe bat by 1 and 2 orders of magnitude, respectively, and 303 decreased binding affinity with mouse ACE2 by ~14-fold (Table S3 ). The L486F 304 mutant also displayed decreased interaction with mouse ACE2 (~1.8-fold), but 305 favored the interaction with hACE2 (Table S3) . Unlike D501N and L486F which 306 increased the adaptation to human receptor and decreased affinity to the mouse 307 receptor, F449Y showed benefit to the association to both hACE2 (~2.7-fold) and 308 mouse ACE2 (~2.5-fold), but abolished the binding to its natural host receptor (Table   309 J o u r n a l P r e -p r o o f S3, Figure 3A and B, Figure S4 ). The Y493Q mutant could not interact with ACE2s Figure 3A and B, Figure S4 ).

Differential amino acids on ACE2 orthologs may also have a significant impact on 318 the interaction with viral RBDs. The complex structure revealed that the Y41 and 319 K353 residues of hACE2 mediate the contacts with the RaTG13 RBD D501. However, 320 Y41 is relatively conserved among the 25 ACE2s analyzed, suggesting that it may not 321 play an important role in determining binding affinity. In contrast, K353 is present in 322 the majority of the ACE2 orthologs, though not in mouse and rat ACE2, where it has 323 been substituted with H353. Thus, considering that the K353 of hACE2 is also a key 324 residue for binding with SARS-CoV-2 RBD and that SARS-CoV-2 is unable to infect 325 mice and rats, we introduced K353H into hACE2 to investigate the relevance for the 326 ability of SARS-CoV-2 RBD to bind to mouse and rat ACE2s. Through flow 327 cytometry analysis, we found that SARS-CoV-2 RBD (containing N501), is more See also Figure S2 and S3, Table S1 and S2. replicates. All data are presented as mean ± SD. *p < 0.05, **p < 0.01, ***p < 0.001, 545 ****p < 0.0001 (Two-tailed unpaired t test). See also Figure S4 and Table S3 . Figure S5 and Table S4 . The former numbers, if there are latter one, in parentheses of hACE2 (RaTG13 RBD) 608 and hACE2 (SARS-CoV-2 RBD) residues represent the number of vdw contacts 609 between the indicated hACE2 residues with RaTG13 RBD or SARS-CoV-2 RBD.

The numbers with underline suggest numbers of potential H-bonds between the pairs 611 of residues. vdw contact was analyzed at a cutoff of 4 Å and H-bonds at a cutoff of (Table S2) . Then, serially diluted wildtype or mutated RaTG13 RBD 772 proteins flowed over the chip in HBST buffer. PD-L1 protein was used as negative 773 control. Binding affinities were measured using a BIAcore 8K (GE Healthcare) at 25 ℃ 774 in the single-cycle mode. Binding kinetics were analyzed with Biacore TM Insight 775 software (GE healthcare) using a 1:1 Langmuir binding model.

The seven recombinant antibodies (2 µg/mL) were first captured on flow cell 2 of 777 the protein A sensor chip (GE Healthcare) at more than 500 response units (Table S4) . Data collection, processing, and refinement statistics are summarized in Table 1 

PHENIX: a comprehensive Python-based system for 880 macromolecular structure solution

SARS-CoV-2 neutralizing antibody structures inform 883 therapeutic strategies

Evolutionary origins of the SARS-CoV-2 sarbecovirus lineage responsible for the COVID-19 886 pandemic

Genomic characterization 888 of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia 889 after visiting Wuhan

The SARS-CoV-2 spike protein has a broad tropism for 892 mammalian ACE2 proteins

Evidence for an ancestral association of 895 human coronavirus 229E with bats

A 897 universal design of betacoronavirus vaccines against COVID-19, MERS, and SARS

Coot: model-building tools for molecular graphics

From "A"IV to "Z"IKV: attacks from emerging and re-emerging pathogens

Adaptation of SARS-CoV-2 in BALB/c mice for testing vaccine efficacy

Isolation and characterization of viruses related to the SARS coronavirus from 907 animals in southern China

Evolutionary arms race 909 between virus and host drives genetic diversity in bat severe acute respiratory syndrome-related 910 coronavirus spike genes

Coronavirus infections in companion animals: 912 virology, epidemiology, clinical and pathologic features

Structure of the S1 subunit C-terminal domain from bat-derived coronavirus HKU5 spike protein

Studies in humanized mice and convalescent humans yield a SARS-CoV-2 antibody 918 cocktail

Identifying SARS-CoV-2-related coronaviruses in Malayan pangolins

Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor

Origin and cross-species transmission of bat coronaviruses in China

Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats

The 937 impact of mutations in SARS-CoV-2 spike on viral infectivity and antigenicity

Bats are natural reservoirs of SARS-like coronaviruses

SARS-CoV-2 and three related coronaviruses utilize multiple ACE2 orthologs and are potently blocked 943 by an improved ACE2-Ig

Cross-species recognition of SARS-CoV-2 to bat ACE2

Peptide presentation by bat MHC class I provides new insight into the antiviral immunity of bats

Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26

Emerging novel coronavirus (2019-nCoV)-current scenario, evolutionary perspective based on genome 954 analysis and recent developments

Neutralization of SARS-CoV-2 lineage B.1.1.7 pseudovirus by BNT162b2 957 vaccine-elicited human sera

Processing of X-ray diffraction data collected in oscillation 959 mode

The egyptian rousette genome reveals unexpected 962 features of bat antiviral immunity

Mapping neutralizing and immunodominant sites on 965 the SARS-CoV-2 spike receptor-binding domain by structure-guided high-resolution serology

Structural 968 basis of receptor recognition by SARS-CoV-2

A 970 human neutralizing antibody targets the receptor-binding site of SARS-CoV-2

Bats and their virome: an important source of emerging viruses 972 capable of infecting humans

Epidemiology, 974 genetic recombination, and pathogenesis of coronaviruses

An unexpected N-terminal loop in PD-1 dominates binding by nivolumab

A novel coronavirus 978 genome identified in a cluster of pneumonia cases-Wuhan

An outbreak 981 of ncip (2019-ncov) infection in China-Wuhan

A novel coronavirus outbreak of global 984 health concern

Bat-origin coronaviruses expand their host 986 range to pigs

Structural and functional basis of SARS-CoV-2 entry by using human ACE2

SARS-CoV-2 and bat RaTG13 spike glycoprotein structures inform on virus evolution and 991 furin-cleavage effects

A new coronavirus associated with human respiratory disease in China

Broad host range of SARS-CoV-2 and the molecular basis for SARS-CoV-2 binding to cat ACE2

Molecular 998 basis of pangolin ACE2 engaged by COVID-19 virus

A 1000 noncompeting pair of human neutralizing antibodies block COVID-19 virus binding to its receptor 1001 ACE2

Isolation of SARS-CoV-2-related coronavirus from Malayan pangolins

Dampened 1005 STING-dependent interferon activation in bats

Structural basis for the recognition of 1007 SARS-CoV-2 by full-length human ACE2

Comparative analysis of bat genomes provides insight into the evolution of 1013 flight and immunity

MotionCor2: 1015 anisotropic correction of beam-induced motion for improved cryo-electron microscopy

A 1018 novel bat coronavirus closely related to SARS-CoV-2 contains natural insertions at the S1/S2 cleavage 1019 site of the spike protein

A pneumonia outbreak associated with a new coronavirus of probable bat origin

A 1024 novel coronavirus from patients with pneumonia in China